Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S

Journal of Infectious Diseases

Volumn 192, Issue 1, 2005, Pages 107-116

  Miyoshi Akiyama, Tohru ^a,b   Takamatsu, Daisuke ^c   Koyanagi, Madoka ^b   Zhao, Jizi ^a,b   Imanishi, Ken'ichi ^b   Uchiyama, Takehiko ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 7; STREPTOLYSIN S; THIOGLYCOLIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL EXUDATE CELL; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BACTERIAL PROTEINS; FEMALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MUTATION; NEUTROPHILS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; THIOGLYCOLATES; TIME FACTORS; VIRULENCE;

EID: 20844439727     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430617     Document Type: Article

References (36)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
2. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003; 3:191-200.
3. Voyich JM, Musser JM, DeLeo FR. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 2004; 6:1117-23.
4. Medina E, Goldmann O, Toppel AW, Chhatwal GS. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J Infect Dis 2003; 187:597-603.
5. Staali L, Morgelin M, Bjorck L, Tapper H. Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 2003; 5:253-65.
6. Betschel SD, Borgia SM, Barg NL, Low DE, De Azavedo JC. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 1998; 66:1671-9.
7. Nizet V, Beall B, Bast DJ, et al. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 2000; 68:4245-54.
8. Dale JB, Chiang EY, Hasty DL, Courtney HS. Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci. Infect Immun 2002; 70:2166-70.
9. Ginsburg I. Is streptolysin S of group A streptococci a virulence factor? APMIS 1999; 107:1051-9.
10. Miyoshi-Akiyama T, Zhao J, Kikuchi K, et al. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci, J Infect Dis 2003; 187:1876-87.
11. Miyoshi-Akiyama T, Zhao J, Kato H, et al. Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol 2003; 47:1589-99.
12. Martin D, Lenardo M. Morphological, biochemical, and flow cytometric assays of apoptosis. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EH, Strober W, eds. Current protocols in immunology. Vol 1. New York: J. Wiley & Sons, 1998: 3.17.2-4.
13. Takamatsu D, Osaki M, Seldzaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 2001; 46:140-8.
14. Hanski E, Horwitz PA, Caparon MG. Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells. Infect Immun 1992; 60:5119-25.
15. Zhao J, Miyoshi-Akiyama T, Uchiyama T. The degrading effect of streptococcal pyrogenic exotoxin B on streptolysin O and their role in the pathogenicity of streptococcal toxic shock syndrome in M4-type group A streptococcus. J Tokyo Women's Med Univ 2003; 73:245.
16. Hirsch S, Gordon S. Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 1983; 18:229-39.
17. Bohatschek M, Werner A, Raivich G. Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency. Exp Neurol 2001; 172:137-52.
18. Henderson RB, Hobbs JA, Mathies M, Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 2003; 102:328-35.
19. Li Z, Sledjeski DD, Kreikemeyer B, Podbielski A, Boyle MD. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol 1999; 181:6019-27.
20. Biswas I, Germon P, McDade K, Scott JR. Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun 2001; 69:7029-38.
21. Fontaine MC, Lee JJ, Kehoe MA. Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun 2003; 71:3857-65.
22. Kobayashi SD, Braughton KR, Whitney AR, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003; 100:10948-53.
23. Shibata S, Yamane H, Konishi K, et al. Induction of macrophage exudation in the inner ear by OK432 treatment. Acta Otolaryngol Suppl 1998; 538:26-31.
24. Kato H, Inoue M, Yamamura Y, et al. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432. Nat Immun Cell Growth Regul 1989; 8:290-300.
25. Santos-Beneit AM, Mollinedo E Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells. J Leukoc Biol 2000; 67:712-24.
26. Hoe NP, Kordari P, Cole R, et al. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis 2000; 182: 1425-36.
27. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160: S5-11.
28. Sierig G, Cywes C, Wessels MR, Ashbaugh CD. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group a streptococci. Infect Immun 2003; 71:446-55.
29. Batsford S, Brundiers M, Schweier O, Horbach E, Monting JS. Antibody to streptococcal cysteine proteinase as a seromarker of group A streptococcal (Streptococcus pyogenes) infections. Scand J Infect Dis 2002; 34:407-12.
30. Basma H, Norrby-Teglund A, McGeer A, et al. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Infect Immun 1998; 66:2279-83.
31. Kuo CF, Wu JJ, Tsai PJ, et al. Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells. Infect Immun 1999; 67:126-30.
32. Yoshida J, Takamura S, Ishibashi T, Nishio M. Antiproliferative and apoptosis-inducing effects of an antitumor glycoprotein from Streptococcus pyogenes. Anticancer Res 1999; 19:1865-71.
33. Tsai PJ, Lin YS, Kuo CF, Lei HY, Wu JJ. Group A Streptococcus induces apoptosis in human epithelial cells. Infect Immun 1999; 67:4334-9.
34. Bricker AL, Cywes C, Ashbaugh CD, Wessels MR. NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol Microbiol 2002; 44:257-69.
35. Voyich JM, Sturdevant DE, Braughton KR, et al. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 2003; 100:1996-2001.
36. Funney DJ. Probit analysis. Cambridge, UK: Cambridge University Press, 1978.